US Broker Ratings

Kamada Ltd. (KMDA) Stock Analysis: Exploring a 107% Potential Upside with a Strong Buy Consensus

Kamada Ltd. (NASDAQ: KMDA), a prominent player in the healthcare sector, finds itself at an intriguing juncture with a compelling opportunity for investors seeking exposure to..

Treace Medical Concepts, Inc. (TMCI) Stock Analysis: A 31.92% Potential Upside in the Healthcare Sector

Treace Medical Concepts, Inc. (NASDAQ: TMCI), a specialized player in the medical devices industry, is making waves with its innovative solutions for bunion correction and related..

Abivax SA (ABVX) Stock Analysis: A 26% Upside Captivates Investor Attention Amid Phase 3 Trials

Abivax SA (ABVX), a prominent player in the biotechnology sector, is catching the eye of investors with its significant 26.20% potential upside, as analysts set their..

ATAI Life Sciences N.V. (ATAI) Stock Analysis: Exploring a Potential 107.57% Upside

ATAI Life Sciences N.V. (NASDAQ: ATAI), a pioneering player in the biotechnology sector, is capturing significant attention from investors with its innovative approach to mental health..

Organogenesis Holdings Inc. (ORGO) Stock Report: Eyeing a Potential 97% Upside with Robust Analyst Ratings

Organogenesis Holdings Inc. (NASDAQ: ORGO), a key player in the regenerative medicine sector, presents an intriguing opportunity for investors with its significant upside potential. Despite recent..

Rapport Therapeutics, Inc. (RAPP)

⚠️ No article content returned.

..

MBX Biosciences (MBX): Analyst Ratings Signal 328% Potential Upside for This Biotech Stock

MBX Biosciences, Inc. (NASDAQ: MBX) stands out in the biotechnology sector with a staggering potential upside of 328.47%, according to recent analyst ratings. This clinical-stage biopharmaceutical..

Keros Therapeutics, Inc. (KROS) Stock Analysis: Unpacking a 67% Potential Upside Amidst Robust Revenue Growth

Keros Therapeutics, Inc. (NASDAQ: KROS), a clinical-stage biopharmaceutical company, has recently piqued investor interest with its compelling growth narrative and substantial potential upside. With a market..

Orthofix Medical Inc. (OFIX) Investor Outlook: Exploring a Potential 49% Upside in the Medical Device Sector

Investors looking for opportunities in the healthcare sector may want to take a closer look at Orthofix Medical Inc. (NASDAQ: OFIX), a key player in the..

SIGA Technologies Inc. (SIGA) Stock Analysis: A Look at its Impressive 271.90% Revenue Growth

Investors with a keen eye on the healthcare sector, particularly within the niche of specialty and generic drug manufacturing, may find SIGA Technologies Inc. (NASDAQ: SIGA)..

Emergent BioSolutions Inc. (EBS) Investor Outlook: Potential 43% Upside Amid Volatile Healthcare Landscape

Emergent BioSolutions Inc. (NYSE: EBS) is a key player in the healthcare sector, specifically within the niche of specialty and generic drug manufacturing. With a market..

Verastem, Inc. (VSTM) Stock Analysis: Exploring a 62.99% Potential Upside in the Biotech Sector

Verastem, Inc. (VSTM) has captured the attention of investors with its promising pipeline in the oncology sector, combined with a compelling potential upside of 62.99%. As..

Altimmune, Inc. (ALT) Stock Analysis: Exploring a Promising 322.74% Potential Upside in Biotech

For individual investors seeking opportunities in the healthcare sector, Altimmune, Inc. (NASDAQ: ALT) offers a fascinating case study in the biotechnology space. With a market capitalization..

Personalis, Inc. (PSNL) Stock Analysis: Navigating the Healthcare Sector with Strong Buy Ratings

Personalis, Inc. (NASDAQ: PSNL) is an intriguing player in the healthcare sector, particularly within the diagnostics and research industry. Headquartered in Fremont, California, this company specializes..

Tourmaline Bio, Inc. (TRML) Stock Analysis: Navigating Growth in the Biotech Sector

Tourmaline Bio, Inc. (NASDAQ: TRML), a burgeoning name in the biotechnology sector, has been capturing investor attention with its promising pipeline aimed at treating complex immune..

Bicycle Therapeutics (BCYC) Investor Outlook: Uncovering a 176% Potential Upside in Biotech Innovation

Bicycle Therapeutics plc (NASDAQ: BCYC), a clinical-stage pharmaceutical company, stands at the forefront of pioneering new classes of medicines for diseases underserved by existing therapies. With..

Prothena Corporation plc (PRTA) Stock Analysis: Potential 28.84% Upside Amidst Promising Clinical Pipeline

Prothena Corporation plc (NASDAQ: PRTA), a Dublin-based biotechnology company, is capturing investor attention with its innovative approach to tackling diseases caused by protein dysregulation. Despite recent..

Day One Biopharmaceuticals, Inc (DAWN) Stock Analysis: A 215% Potential Upside Awaits Patient Investors

Day One Biopharmaceuticals, Inc (NASDAQ: DAWN), a burgeoning player in the healthcare sector, is making significant strides in the biotechnology industry. With a market capitalization of..

LifeMD, Inc. (LFMD) Stock Analysis: Exploring a Potential 100% Upside as Telehealth Expands

LifeMD, Inc. (LFMD) is a burgeoning player in the healthcare sector, specifically within the health information services industry. With a market cap of $304.89 million, LifeMD..

Spyre Therapeutics, Inc. (SYRE) Stock Analysis: A Biotech Innovator with 137.90% Potential Upside

Spyre Therapeutics, Inc. (NASDAQ: SYRE), a promising player in the biotechnology sector, is grabbing attention with its cutting-edge research in inflammatory bowel disease (IBD) and a..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds